VCP
LABU icon

Verus Capital Partners’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Verus Capital Partners’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$6K Hold
13
– – ﹤0.01% 1139
2019
Q4 		$14K Buy
+13
New +$11.7K ﹤0.01% 1022

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Verus Capital Partners's LABU Position: Q1 2020 in Review

Verus Capital Partners held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q1 2020 at 13 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

Verus Capital Partners first reported a position in LABU in Q4 2019 and has held it in 2 quarters since. The position peaked at $14K in Q4 2019. 19 funds tracked by Wall St. Rank hold LABU as of Q1 2020.

  • Verus Capital Partners held 13 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $6K as of Q1 2020.
  • Verus Capital Partners left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q1 2020.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #1139 holding.
  • Verus Capital Partners first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $14K in Q4 2019.
  • 19 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.